Margaret Amy Chang MD MS

Retinal Disease

Retinal Consultants

3939 J StSte 106Sacramento, CA 95819
Phone+1 916-454-4861
Fax+1 916-454-3603

Dr. Chang is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chang's full profile Already have an account?

Education & Training

Johns Hopkins UniversityResidency, Ophthalmology, 2003 - 2005
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 2002 - 2003
Columbia University Vagelos College of Physicians and SurgeonsClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2008 - 2027
MD State Medical License 2006 - 2008
PA State Medical License 2002 - 2003
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification HouseCalls, TeleVox Software, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014, 2016-2017

Publications & Presentations

PubMed

MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy.
Avery W Zhou, Ryan A Sahraravand, Liisa M Baumann, Gail Megan Teagle, Jeremiah Brown
Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2026-01-01
3 citations
Structural Updates to the Implant and Refill Needle of the Port Delivery Platform.
Dante J Pieramici, Peter A Campochiaro, Margaret Chang, Ian Pearce, Carl D Regillo
Translational Vision Science & Technology. 2025-04-01
9 citations
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.
Dante J Pieramici, Carl C Awh, Margaret Chang, Andres Emanuelli, Nancy M Holekamp
JAMA Ophthalmology. 2025-04-01

Press Mentions

Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Surgical Interventions for Retinal Vascular Diseases: A Deep Dive into the DataSeptember 7th, 2023
New Geographic Atrophy Drugs: The Good, the Bad, and the UnknownMay 14th, 2024